A Phase II Study of RFS 2000 (Rubitecan, 9-Nitro-Camptothecin, 9-NC) in Patients With Advanced Gastric Carcinoma.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2008
At a glance
- Drugs Rubitecan (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 10 Sep 2005 New trial record.